- Home
- IOBT vs PYPD Comparison
IOBT vs PYPD Comparison
Compare IOBT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- PYPD
- Stock Information
- Founded
- IOBT 2014
- PYPD 2008
- Country
- IOBT Denmark
- PYPD Israel
- Employees
- IOBT N/A
- PYPD 61
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- PYPD Medical/Dental Instruments
- Sector
- IOBT Health Care
- PYPD Health Care
- Exchange
- IOBT Nasdaq
- PYPD Nasdaq
- Market Cap
- IOBT 50.5M
- PYPD 60.4M
- IPO Year
- IOBT 2021
- PYPD 2020
- Fundamental
- Price
- IOBT $0.87
- PYPD $3.80
- Analyst Decision
- IOBT Buy
- PYPD Strong Buy
- Analyst Count
- IOBT 4
- PYPD 5
- Target Price
- IOBT $3.50
- PYPD $12.00
- AVG Volume (30 Days)
- IOBT 7.4M
- PYPD 92.7K
- Earning Date
- IOBT 11-07-2025
- PYPD 11-12-2025
- Dividend Yield
- IOBT N/A
- PYPD N/A
- EPS Growth
- IOBT N/A
- PYPD N/A
- EPS
- IOBT N/A
- PYPD N/A
- Revenue
- IOBT N/A
- PYPD N/A
- Revenue This Year
- IOBT N/A
- PYPD N/A
- Revenue Next Year
- IOBT N/A
- PYPD N/A
- P/E Ratio
- IOBT N/A
- PYPD N/A
- Revenue Growth
- IOBT N/A
- PYPD N/A
- 52 Week Low
- IOBT $0.32
- PYPD $2.30
- 52 Week High
- IOBT $2.79
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- IOBT 47.19
- PYPD 68.11
- Support Level
- IOBT $0.62
- PYPD $3.10
- Resistance Level
- IOBT $1.23
- PYPD $3.50
- Average True Range (ATR)
- IOBT 0.14
- PYPD 0.18
- MACD
- IOBT 0.06
- PYPD 0.06
- Stochastic Oscillator
- IOBT 47.74
- PYPD 94.87
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.